시장보고서
상품코드
1462932

세계 용련균 감염증 치료 시장 : 진단별, 제품 유형별, 최종 사용자별, 국가별, 지역별- 산업 분석, 시장 규모, 시장 점유율 예측(2024년-2032년)

Strep Throat Treatment Market, By Diagnosis, By Product Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 376 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

용련균 감염증 치료 시장 규모는 2023년 21억 1,850만 달러로 평가되었고 2024년부터 2032년까지 복합 연간 성장률(CAGR) 4.5%로 확대될 전망입니다.

용련균 감염증 치료 시장 - 시장 역학

용련균 감염, 특히 소아와 청소년 사이에서 증가하여 시장 수요를 촉진

용련균 감염, 특히 소아 및 청소년에서 감염 사례가 증가함에 따라 효과적인 치료 옵션에 대한 수요가 증가하고 있습니다. 증례의 계절 변동에 의해 피크시 시장 활동이 활성화하는 경우가 많습니다. 공중보건 캠페인과 교육적 이니셔티브를 통한 인지도의 향상으로 증상을 경험했을 때 의료기관을 진찰하고 치료받는 사람의 수가 늘어나 진단 및 치료 개입에 대한 수요를 끌어올리고 있습니다. 신속 진단 검사의 기술적 진보는 보다 빠르고 정확한 진단을 용이하게 하고 시기 적절한 치료로 이어지고 시장 성장을 가속합니다. 내성 패턴이 진화하고 있기 때문에 내성균을 최소화하면서 효과성을 높이는 데 중점을 둔 항생제 최종 사용자 규제의 지속적인 개발이 필수적입니다. 항생제의 적절한 사용을 제안하는 스튜어드십 프로그램도 내성에 대한 우려를 해결함으로써 시장 역학에 영향을 미칩니다. 학교로 돌아가기 전에 용련균 감염증의 어린이들에게 항생제 치료를 의무화하는 학교 보건 정책은 간접적으로 치료제 수요를 밀어 올리고 있습니다. 전염병 관리 및 예방을 목적으로 하는 세계보건 이니셔티브는 용련균 감염과 같은 증상에 대한 대처의 중요성을 더욱 강조하고 시장 역학에 영향을 미치고 있습니다. 예를 들어, 국립 의학 도서관의 데이터에 따르면, 인두염은 연간 4,000 만 명 이상의 건강 관리 제공업체의 방문을 차지하고 있으며 대부분의 사람들은 인두염을 포함한 여러 바이러스성 호흡기 감염을 연간 경험합니다.

용련균 감염증 치료 시장 - 주요 인사이트력

우리 리서치 애널리스트의 분석에 따르면 시장은 예측 기간(2024년-2032년)에 연간 약 4.5%의 복합 연간 성장률(CAGR)로 성장할 것으로 추정됩니다.

진단별로, 항체 검사는 2023년에 가장 큰 시장 점유율을 나타낼 것으로 예측됩니다.

최종 사용자별로 2023년에는 병원이 주요했습니다.

지역별로는 북미가 2023년 주요 수익원이 되었습니다.

용련균 감염증 치료 시장 - 세분화 분석 :

용련균 감염 치료 시장은 진단, 제품 유형, 최종 사용자 및 지역에 따라 세분화됩니다.

시장은 진단별로 4가지 범주로 나뉩니다: 항체 검사, 신체 검사, 인두 배양 및 기타 양식. 항체 검사는 질병의 존재를 검출하기 위해 이러한 진단 절차에 대한 의존도가 증가함에 따라 예측 기간 동안이 범주에서 가장 큰 점유율을 차지할 것으로 예측됩니다.

시장은 최종 사용자별로 병원, 진단 실험실, 전문 클리닉 및 기타 건강 관리 시설의 네 가지 범주로 분류됩니다. 이 중 진단검사실은 예측기간을 통해 수익에 크게 기여할 것으로 예상됩니다. 병원은 종합적인 의료 서비스와 전문 장비로 용련균 감염의 진단과 치료에 중심적인 역할을 합니다. 병원에는 항체 검사나 인두 배양을 실시할 수 있는 설비가 완비된 검사실이 있는 경우가 많아, 신속하고 정확한 진단이 가능합니다. 또한, 병원은 용련균 감염을 효과적으로 관리하기 위해 항생제 및 지원 요법을 포함한 다양한 치료법을 제공합니다. 건강 관리에 대한 집적 접근법을 통해 환자는 개별 요구에 맞는 종합적인 치료를 받을 수 있습니다.

용련균 감염증 치료 시장 - 지리적 인사이트

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양 및 중동 및 아프리카 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 의해 더 나뉩니다.

용련균 감염증 치료 시장 - 경쟁 구도:

용련균 감염증 치료 시장에서 기업은 시장에서의 존재감을 높이고 제품 제공을 확대하기 위해 제휴 전략을 채용하는 것이 늘고 있습니다. 제약회사, 의료 제공자, 연구기관, 정부기관과의 제휴에 의해 기업은 보완적인 전문지식, 자원, 네트워크를 활용해, 혁신적인 치료법의 개발, 진단 툴의 개선, 유통 채널의 합리화를 도울 수 있습니다. 이러한 파트너십을 통해 기업은 새로운 기회를 활용하고 아직 치료가 없는 질환에 대해 용련균 감염의 효과적인 관리를 위한 종합적인 솔루션을 제공할 수 있습니다.

목차

제1장 용련균 감염증 치료 시장 개요

  • 조사 범위
  • 시장추정년

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 용련균 감염증 치료의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 용련균 감염증 치료 산업의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀 분석

제5장 용련균 감염증 치료 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 용련균 감염증 치료 시장 상황

  • 용련균 감염증 치료제 시장 점유율 분석(2023년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥기업의 분석

제7장 용련균 감염증 치료 시장- 진단별

  • 개요
    • 진단별 부문 점유율 분석
    • 항체 검사
    • 신체 검사
    • 인두 배양
    • 기타 검사 방법

제8장 용련균 감염증 치료 시장-제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 페니실린
    • 아목시실린

제9장 용련균 감염증 치료 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원
    • 진단 실험실
    • 전문 클리닉
    • 기타 의료시설

제10장 용련균 감염증 치료 시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 용련균 감염증 치료 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • Pfizer Inc.
    • Sanofi
    • Astrazeneca
    • Novartis AG
    • Bayer AG
    • GSK plc
    • Melinta Therapeutics
    • Amgen Inc.
    • Others

제12장 애널리스트의 전방위 전망

BJH 24.05.23

REPORT HIGHLIGHT

Strep Throat Treatment Market size was valued at USD 2,118.5 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

Strep throat, also referred to as Group A Streptococcal (GAS) pharyngitis, is a bacterial infection affecting the throat and tonsils caused by Streptococcus pyogenes bacteria. If left untreated, it can lead to severe complications. Various treatment options are available for strep throat, with the most common being oral antibiotics such as penicillin or amoxicillin. These antibiotics effectively eradicate the bacteria responsible for the infection and are typically prescribed for a duration of 10 days, providing prompt relief from symptoms and preventing further spread of the infection. Additionally, throat lozenges or sprays containing anesthetic agents like benzocaine offer temporary relief from throat discomfort.

Strep Throat Treatment Market- Market Dynamics

Rise in strep throat cases, especially among children and adolescents to propel market demand

With a rise in strep throat cases, especially among children and adolescents, the demand for effective treatment options is increasing. Seasonal fluctuations in cases often lead to heightened market activity during peak periods. Increased awareness through public health campaigns and educational initiatives has resulted in a greater number of individuals seeking medical attention and treatment upon experiencing symptoms, thereby boosting the demand for diagnostic and therapeutic interventions. Technological advancements in rapid diagnostic tests have facilitated quicker and more accurate diagnosis, leading to timely treatments and driving market growth. Ongoing developments in antibiotic end Userulations are essential due to evolving resistance patterns, with a focus on enhancing effectiveness while minimizing resistance. Stewardship programs advocating judicious antibiotic use also impact market dynamics by addressing concerns over resistance. School health policies mandating antibiotic treatment for children with strep throat before returning to school indirectly drive demand for treatments. Global health initiatives aimed at managing and preventing infectious diseases further underscore the importance of addressing conditions like strep throat, influencing market dynamics. For example, data from the National Library of Medicine indicates that pharyngitis accounts for over 40 million healthcare provider visits annually, with most individuals experiencing multiple viral upper respiratory tract infections, including pharyngitis, per year.

Strep Throat Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on Diagnosis segmentation, antibody tests was predicted to show maximum market share in the year 2023

Based on End User segmentation, hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Strep Throat Treatment Market- Segmentation Analysis:

The Global Strep Throat Treatment Market is segmented on the basis of Diagnosis, Product Type, End User, and Region.

The market is divided into four categories based on Diagnosis: antibody tests, physical examinations, throat cultures, and other modalities. Antibody tests are projected to hold the largest share in this category during the forecast period, driven by the increasing reliance on these diagnostic procedures to detect the presence of the disease.

The market is divided into four categories based on End User: hospitals, diagnostic laboratories, specialty clinics, and other healthcare facilities. Among these, diagnostic laboratories are anticipated to contribute significantly to revenue generation throughout the forecast period. Hospitals play a central role in the diagnosis and treatment of strep throat due to their comprehensive healthcare services and specialized facilities. Hospitals often have well-equipped laboratories capable of conducting antibody tests and throat cultures, allowing for prompt and accurate diagnosis. Additionally, hospitals provide a range of treatment options, including antibiotic therapy and supportive care, to manage strep throat effectively. Their multidisciplinary approach to healthcare ensures that patients receive comprehensive treatment tailored to their individual needs.

Strep Throat Treatment Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Strep Throat Treatment Market- Competitive Landscape:

In the Strep Throat Treatment market, companies are increasingly adopting partnership strategies to enhance their market presence and expand their product offerings. Collaborations with pharmaceutical companies, healthcare providers, research institutions, and government agencies allow companies to leverage complementary expertise, resources, and networks to develop innovative treatments, improve diagnostic tools, and streamline distribution channels. These partnerships enable companies to capitalize on emerging opportunities, address unmet medical needs, and provide comprehensive solutions for the effective management of strep throat.

Recent Developments:

In July 2022, Taiho Pharmaceutical Co., Ltd., a pharmaceutical company, introduced the PITAS throat troche series in Singapore. These film-type troches adhere to the roof of the mouth and effectively alleviate throat pain and swelling.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL STREP THROAT TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Pfizer Inc.

Sanofi

Astrazeneca

Novartis AG

Bayer AG

GSK plc

Melinta Therapeutics

Amgen Inc.

Others

GLOBAL STREP THROAT TREATMENT MARKET, BY DIAGNOSIS - MARKET ANALYSIS, 2019 - 2032

  • Antibody tests
  • Physical examinations
  • Throat cultures
  • Other modalities

GLOBAL STREP THROAT TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Penicillin
  • Amoxicillin

GLOBAL STREP THROAT TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic laboratories
  • Specialty clinics
  • Other healthcare facilities

GLOBAL STREP THROAT TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Strep Throat Treatment Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Strep Throat Treatment Market Snippet by Diagnosis
    • 2.1.2.Strep Throat Treatment Market Snippet by Product Type
    • 2.1.3.Strep Throat Treatment Market Snippet by End User
    • 2.1.4.Strep Throat Treatment Market Snippet by Country
    • 2.1.5.Strep Throat Treatment Market Snippet by Region
  • 2.2.Competitive Insights

3.Strep Throat Treatment Key Market Trends

  • 3.1.Strep Throat Treatment Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Strep Throat Treatment Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Strep Throat Treatment Market Opportunities
  • 3.4.Strep Throat Treatment Market Future Trends

4.Strep Throat Treatment Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Strep Throat Treatment Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Strep Throat Treatment Market Landscape

  • 6.1.Strep Throat Treatment Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Strep Throat Treatment Market - By Diagnosis

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2.Antibody tests
    • 7.1.3.Physical examinations
    • 7.1.4.Throat cultures
    • 7.1.5.Other modalities

8.Strep Throat Treatment Market - By Product Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 8.1.2.Penicillin
    • 8.1.3.Amoxicillin

9.Strep Throat Treatment Market - By End User

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2.Hospitals
    • 9.1.3.Diagnostic laboratories
    • 9.1.4.Specialty clinics
    • 9.1.5.Other healthcare facilities

10.Strep Throat Treatment Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Strep Throat Treatment Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Strep Throat Treatment Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Strep Throat Treatment Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Strep Throat Treatment Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Strep Throat Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Strep Throat Treatment Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Pfizer Inc.
    • 11.2.2.Sanofi
    • 11.2.3.Astrazeneca
    • 11.2.4.Novartis AG
    • 11.2.5.Bayer AG
    • 11.2.6.GSK plc
    • 11.2.7.Melinta Therapeutics
    • 11.2.8.Amgen Inc.
    • 11.2.9.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제